
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.920 | 0.920 | 0.000 |
Shares | 99.080 | 99.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 9.810 | 14.981 |
Price to Book | 2.264 | 2.117 |
Price to Sales | 1.805 | 1.742 |
Price to Cash Flow | 11.997 | 11.888 |
Dividend Yield | 2.234 | 2.803 |
5 Years Earnings Growth | 7.347 | 7.909 |
Name | Net % | Category Average |
---|---|---|
Industrials | 44.750 | 39.953 |
Financial Services | 22.440 | 20.701 |
Healthcare | 11.080 | 9.935 |
Technology | 8.320 | 8.685 |
Real Estate | 4.890 | 4.392 |
Consumer Defensive | 4.880 | 4.794 |
Consumer Cyclical | 2.390 | 5.803 |
Communication Services | 1.250 | 3.934 |
Number of long holdings: 29
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Investor B | SE0015811963 | 8.49 | 286.2 | +1.35% | |
Atlas Copco A | SE0017486889 | 8.45 | 155.4 | +1.50% | |
SEB A | SE0000148884 | 8.01 | 149.70 | +1.25% | |
Hexagon B | SE0015961909 | 6.25 | 92.86 | +3.75% | |
Volvo B | SE0000115446 | 6.09 | 263.60 | +1.85% | |
ASSA ABLOY B | SE0007100581 | 4.90 | 290.0 | +2.62% | |
AstraZeneca | GB0009895292 | 4.89 | 10,400.0 | -0.42% | |
AAK | SE0011337708 | 4.83 | 249.0 | -2.28% | |
Sandvik AB | SE0000667891 | 4.76 | 203.40 | +1.80% | |
Securitas B | SE0000163594 | 4.75 | 148.90 | +1.36% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Enter Smabolagsfond A | 2.77B | -4.27 | -4.52 | - | ||
Enter Smabolagsfond B | 2.77B | -4.09 | -3.81 | - | ||
Enter Select | 2.61B | 0.13 | 2.12 | 6.68 | ||
Enter Sverige Pro | 335.04M | 7.47 | -0.95 | 9.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review